Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMAX CORP Director's Dealing 2023

Mar 13, 2023

31800_dirs_2023-03-13_05a36a6c-fe2f-4fee-a43e-1124e884e58d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMAX CORP (IMAX)
CIK: 0000921582
Period of Report: 2023-03-07

Reporting Person: LISTER ROBERT D (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-07 common shares M 11674 $0.00 Acquired 104478 Direct
2023-03-07 common shares M 23586 $0.00 Acquired 128064 Direct
2023-03-07 common shares M 7055 $0.00 Acquired 135119 Direct
2023-03-07 common shares M 14733 $0.00 Acquired 149852 Direct
2023-03-07 common shares M 11957 $0.00 Acquired 161809 Direct
2023-03-07 common shares F 38163 $18.43 Disposed 123646 Direct
2023-03-07 common shares A 24764 $0.00 Acquired 148410 Direct
2023-03-07 common shares F 13792 $18.43 Disposed 134618 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-07 restricted share units $0.00 M 11674 Disposed common shares (11674) Direct
2023-03-07 restricted share units $0.00 M 23586 Disposed common shares (23586) Direct
2023-03-07 restricted share units $0.00 M 7055 Disposed common shares (7055) Direct
2023-03-07 restricted share units $0.00 M 14733 Disposed common shares (14733) Direct
2023-03-07 restricted share units $0.00 M 11957 Disposed common shares (11957) Direct
2023-03-07 restricted share units $0.00 A 38873 Acquired common shares (38873) Direct

Holdings (Non-Derivative)

Security Shares Ownership
common shares (opening balance) 92804 Direct

Footnotes

F1: Represents the conversion upon vesting of restricted share units into common shares.

F2: Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.

F3: Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2020. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.

F4: Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions.

F5: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

F6: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

F7: The restricted share units vest and will be converted to common shares in four installments: 11,671 on each of March 7, 2020, March 7, 2021 and March 7, 2022 and 11,674 on March 7, 2023.

F8: The restricted share units vest and will be converted to common shares in three installments: 23,584 on each of March 7, 2021 and March 7, 2022 and 23,586 on March 7, 2023.

F9: The restricted share units vest and will be converted to common shares in two equal installments on each of the first two anniversaries of the grant date.

F10: The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.

F11: The restricted share units vest and will be converted to common shares in three installments: 11,957 on each of March 7, 2023 and March 7, 2024 and 11,959 on March 7, 2025.

F12: The restricted share units vest and will be converted to common shares in three installments: 12,957 on each of March 7, 2024 and March 7, 2025 and 13,406 March 7, 2026.

F13: This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 145,962, 77,522 and 134,618, respectively. The number of outstanding options reflects the expiration of options to purchase 54,805 common shares on March 7, 2023. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d).